My research focuses on the disease pathogenesis of ischaemic vascular retinal diseases, particularly diabetic retinopathy. I aim to unravel the early mechanisms driving vascular dysfunction and neurovascular damage, providing insight into how these processes initiate and progress. By characterising the cellular and molecular pathways involved, my work seeks to identify novel therapeutic targets and test potential interventions, with the goal of preventing vision loss and improving treatment strategies for patients affected by these debilitating conditions.